Understanding FDA Category 1 vs Category 2 Peptides
A clear breakdown of the FDA's bulk substance classification system and what each category means for your sourcing decisions.
For Businesses
Sourcing guides, compliance checklists, regulatory explainers, and business education for peptide operators.
A clear breakdown of the FDA's bulk substance classification system and what each category means for your sourcing decisions.
The essential questions to ask, documents to verify, and red flags to watch for when evaluating peptide suppliers for your business.
The difference between traditional compounding pharmacies and outsourcing facilities, and how it affects your peptide sourcing strategy.
Storage requirements, shipping best practices, and chain-of-custody documentation for peptide products.
With FDA issuing warning letters and declaring shortages resolved, the compounded GLP-1 landscape is shifting. Here's what it means for your business.
How to communicate evidence levels, regulatory status, and safety profiles to patients in a way that builds trust and informed consent.
Why Stripe and Square flag peptide businesses, how to get approved, and the role of certifications like PepMD and LegitScript.
A data-driven overview of the peptide therapy market — demand trends, regulatory shifts, competitive landscape, and growth opportunities.
More articles coming soon. Content is updated regularly and will be expanded with OpenClaw automation.
Whether you're sourcing suppliers or finding providers, start your journey with confidence today.